Malignant Bile Duct Neoplasm
Associated Genetic Biomarkers
Malignant bile duct neoplasms most frequently harbor alterations in TP53, KRAS, IDH1, ARID1A, and CDKN2A .
TP53 Mutation, KRAS Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, and KRAS Exon 2 Mutation are the most common alterations in malignant bile duct neoplasm .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.